Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Platelet Services is a private UK contract research organization focused on pre-clinical platelet function testing for drug discovery and development programs. The company provides standard and customized in vitro assays to evaluate compound effects on platelet activation, aggregation, viability, and platelet-leukocyte interactions. Its services are used both to support anti-platelet drug programs and to de-risk platelet-related safety liabilities in non-platelet therapeutics, including monoclonal antibodies, oligonucleotides, and kinase inhibitors. Platelet Services appears to operate as a specialist scientific services business rather than a therapeutic product developer, working with biotech, pharma, research organizations, and universities. The company has roots in the University of Nottingham platelet research ecosystem and Platelet Solutions, and has expanded its assay-development and higher-throughput testing capabilities over time.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Platelet Services.